๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
TQB2928 is a promising new molecular entity that mediates blockade of CD47 ...
Status
Unknown
Location
Sun Yat-sen University Cancer Cen
Start Date
2022-01-24
Trial ID
NCT05192512
Treatments Being Tested
This study will evaluate the safety and efficiency of TQB2928 injection com...
Status
Terminated
Location
The Second People's Hospital of Hefei
Start Date
2024-05-24
Trial ID
NCT06297642
Treatments Being Tested
This is a multicenter, open-label, multi-cohort Phase Ib trial to evaluate ...
Status
Terminated
Location
Beijing jishuitan hospital
Start Date
2024-02-15
Trial ID
NCT06438783
Treatments Being Tested
This is a Phase Ib study to evaluate the safety, tolerability, and efficacy...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-09
Trial ID
NCT06585059
Treatments Being Tested
This study carried out a phase Ib clinical trial of TQB2928 injection combi...
Status
Unknown
Location
Peking University People's Hospital
Start Date
2023-09
Trial ID
NCT06008405
Treatments Being Tested
TQB2928 is a promising new molecular entity that mediates blockade of CD47 ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-08-01
Trial ID
NCT04854681
Treatments Being Tested